HRT Financial’s CalciMedica CALC Stock Holding History

HRT Financial’s Portfolio CALC Stock Details CALC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21K	Buy	+39,699	New	+$80.6K	﹤0.01%	3569
2021 Q3	–	Sell	-2,016	Closed	-$153K	–	3313
2021 Q2	$153K	Buy	+2,016	New	+$132K	﹤0.01%	2476

Other funds holding CALC

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

1WA

180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return

SFFS

Stonehage Fleming Financial Services St. Helier, Jersey $2.75B AUM 13.81% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

HRT Financial's CALC Position: Q1 2026 in Review

HRT Financial opened a new position in CalciMedica (CALC) in Q1 2026: 39,699 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #3569 among its holdings. This is a return to the name: HRT Financial previously reported a position in CALC as recently as Q2 2021.

HRT Financial first reported a position in CALC in Q2 2021 and has held it in 2 quarters since. The position peaked at $153K in Q2 2021. 27 funds tracked by Wall St. Rank hold CALC as of Q1 2026.

HRT Financial held 39,699 shares of CalciMedica worth $21K as of Q1 2026.
CalciMedica was a new HRT Financial position in Q1 2026.
CalciMedica made up ﹤0.01% of HRT Financial's portfolio in Q1 2026, its #3569 holding.
HRT Financial first reported a position in CalciMedica in Q2 2021 and has held it in 2 quarters since.
HRT Financial's CalciMedica position peaked at $153K in Q2 2021.
27 funds tracked by Wall St. Rank held CalciMedica as of Q1 2026.

Based on HRT Financial's 13F filing for Q1 2026, filed 14 May 2026.